Alnylam Pharmaceuticals
TubeHealth is an independent service and is not affiliated with or endorsed by YouTube or Google.
Data displayed on this page is retrieved via YouTube API Services.
Updated:
Alnylam Pharmaceuticals Channel Description Snapshot
Channel Description
Alnylam has pioneered RNAi therapeutics - and innovative new class of medicines based on RNA interference (RNAi) - a breakthrough discovery in biology that was awarded the Nobel Prize in Medicine and Physiology. RNAi therapeutics work by silencing the genes that cause or contribute to diseases.
Our vision is to harness the potential of RNAi therapeutics to transform the lives of people living with both rare and more common diseases. We are relentless in our pursuit of new treatments. Because patients shouldn’t have to wait for hope.
Alnylam is a global and diverse company of more than 2,000 employees in 26 countries. We are based in Cambridge, Massachusetts, USA.
We encourage you to learn more about our science, pipeline, programs and career opportunities at http://www.alnylam.com/
Our vision is to harness the potential of RNAi therapeutics to transform the lives of people living with both rare and more common diseases. We are relentless in our pursuit of new treatments. Because patients shouldn’t have to wait for hope.
Alnylam is a global and diverse company of more than 2,000 employees in 26 countries. We are based in Cambridge, Massachusetts, USA.
We encourage you to learn more about our science, pipeline, programs and career opportunities at http://www.alnylam.com/
About This Page
Methodology: This page displays a snapshot of publicly available creator information retrieved via YouTube API Services.
Snapshot
Snapshot Date:
Data Source: Public data retrieved via YouTube API Services
Data is refreshed at least once every 30 days.